News
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
Peptides are gaining steam as ways to fight aging, build muscle, and burn fat. Here's what doctors want you to know before you take the shots.
13h
HealthDay on MSNGLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...
Computational models of the glucoregulatory system constitute a powerful tool for preclinical evaluation and mechanistic insight into therapeutics. However, in the case of diabetes, there is a dearth ...
Peter Kyle said he wants the likes of Wegovy and Mounjaro to be 'widely used' and made 'available to everyone from every ...
Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...
Data suggests that some sectors of Europe's confectionery sector are declining. Could GLP-1s have a role to play in this?
Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results